Skip to content
10-K

Annual Report

Immunic, Inc. IMUX

0001280776-26-000005

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 130.46M sh
Shares Diluted FY 2025 · Dec 31, 2025 155.69M sh
Shares Diluted FY 2025 · Dec 31, 2024 100.17M sh
Capex FY 2025 · Dec 31, 2025 $161K
Capex FY 2025 · Dec 31, 2024 $264K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$85.81M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$84.77M
Cash And Equivalents FY 2025 · Dec 31, 2025 $15.48M
Cash And Equivalents FY 2025 · Dec 31, 2024 $35.67M
Stockholders Equity FY 2025 · Dec 31, 2025 −$6.67M
Stockholders Equity FY 2025 · Dec 31, 2024 $18.43M
Stockholders Equity FY 2025 · Dec 31, 2023 $28.93M
Current Liabilities FY 2025 · Dec 31, 2025 $30.62M
Current Liabilities FY 2025 · Dec 31, 2024 $22.18M
Total Liabilities FY 2025 · Dec 31, 2025 $30.73M
Total Liabilities FY 2025 · Dec 31, 2024 $22.44M
Current Assets FY 2025 · Dec 31, 2025 $22.87M
Current Assets FY 2025 · Dec 31, 2024 $39.33M
Total Assets FY 2025 · Dec 31, 2025 $24.05M
Total Assets FY 2025 · Dec 31, 2024 $40.87M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.62
Eps Diluted FY 2025 · Dec 31, 2024 −$1.00
Eps Basic FY 2025 · Dec 31, 2025 −$0.62
Eps Basic FY 2025 · Dec 31, 2024 −$1.00
Sga Expense FY 2025 · Dec 31, 2025 $21.25M
Sga Expense FY 2025 · Dec 31, 2024 $18.01M
Rd Expense FY 2025 · Dec 31, 2025 $81.98M
Rd Expense FY 2025 · Dec 31, 2024 $80.05M
Net Income FY 2025 · Dec 31, 2025 −$97.17M
Net Income FY 2025 · Dec 31, 2024 −$100.51M
Operating Income FY 2025 · Dec 31, 2025 −$103.23M
Operating Income FY 2025 · Dec 31, 2024 −$98.05M